Top compounds associated with response to UEVLD


Feature Type Standardized
Nominal ANOVA
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.16 6e-05
mRNA Bax channel blocker CTRPv2 pan-cancer AAC -0.18 6e-05
mRNA manumycin A CTRPv2 pan-cancer AAC -0.15 7e-05
mRNA rigosertib CTRPv2 pan-cancer AAC -0.15 7e-05
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 7e-05
mRNA MK 1775 CTRPv2 pan-cancer AAC -0.16 9e-05
mRNA clofarabine CTRPv2 pan-cancer AAC -0.13 0.0001
mRNA SN-38 CTRPv2 pan-cancer AAC -0.16 0.0001
mRNA paclitaxel CTRPv2 pan-cancer AAC -0.15 0.0001
mRNA BMS-345541 GDSC1000 pan-cancer AAC -0.14 0.0001
Download CSV